Puma Biotechnology (PBYI) Assets (2010 - 2026)
Puma Biotechnology's Assets was $192.74 million in Q2 2026, down 1.1% from $194.92 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Assets at Puma Biotechnology came in at $216.3 million, up 1.4% from FY2024.
- Assets shows a five-year compound annual growth rate of -2.4% (FY2020 to FY2025).
- In earlier years, Assets was $213.33 million in FY2024 (-7.5%), $230.53 million in FY2023 (+3.8%), $222.06 million in FY2022 (-2.0%) and $226.59 million in FY2021 (-7.2%).
- Quarterly Assets has moved between $192.7 million (Q1 2026) and $230.53 million (Q4 2023) over five years.
- Compared with a year earlier, Assets was higher in two of the last eight quarters, with an average decline of 2.7%.
- The best year-over-year quarter for Assets over five years was Q1 2024 (growth of 9.1%); the worst was Q2 2022 (a decline of 25.5%).
- Per Business Quant data, PBYI's Assets in the three quarters before Q2 2026 was $192.7 million (Q1 2026), $216.3 million (Q4 2025) and $202.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Puma Biotechnology | 499.78 Mn | 112.42 Mn | 44.03 Mn | 192.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 192.74 Mn |
| Mar 31, 2026 | 192.70 Mn |
| Dec 31, 2025 | 216.30 Mn |
| Sep 30, 2025 | 202.86 Mn |
| Jun 30, 2025 | 194.92 Mn |
| Mar 31, 2025 | 196.18 Mn |
| Dec 31, 2024 | 213.33 Mn |
| Sep 30, 2024 | 220.72 Mn |
| Jun 30, 2024 | 205.00 Mn |
| Mar 31, 2024 | 214.15 Mn |
| Dec 31, 2023 | 230.53 Mn |
| Sep 30, 2023 | 203.61 Mn |
| Jun 30, 2023 | 200.49 Mn |
| Mar 31, 2023 | 196.26 Mn |
| Dec 31, 2022 | 222.06 Mn |
| Sep 30, 2022 | 198.77 Mn |
| Jun 30, 2022 | 193.65 Mn |
| Mar 31, 2022 | 200.69 Mn |
| Dec 31, 2021 | 226.59 Mn |
| Sep 30, 2021 | 226.29 Mn |
API Access
Puma Biotechnology Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();